Novo shares lost nearly a fifth of their value after an experimental combination treatment called cagrisema fell short of the ...

An startup formed by KdT Ventures intends to test the drug, which was once licensed to Merck and evaluated in multiple ...

The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest ...

Dec. 21, 2024 – Dec. 31, 2024 • New York, NY, USA, New York ...